| Document Date: 2014-10-20 13:12:54
Open Document File Size: 586,78 KBShare Result on Facebook
City Wayne / / Company Bayer HealthCare Pharmaceuticals Inc. / Ames / / Country Canada / / Event Product Issues / Product Recall / / IndustryTerm topical products / corticosteroid-containing product / / MedicalCondition intracranial hypertension / papilledema / allergic contact dermatitis / Skin Irritation If irritation / Concomitant Skin Infections / headaches / atopic dermatitis / lymphoma / telangiectasia / disease / headache / latent diabetes / liver failure / Carcinogenesis / hyperglycemia / dermatitis / folliculitis / hypopigmentation / acneiform eruptions / Skin Irritation / itching / secondary infection / latent diabetes mellitus / miliaria / disorder / perioral dermatitis / hypersensitivity / infection / irritation / inflammation / application site pruritus / telangiectasias / rash / syndrome / adrenal insufficiency / / MedicalTreatment drug therapy / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Position Investigator / physician / / Product DESONATE / cosyntropin / drug / edetate disodium / desonide / ACTH / / ProvinceOrState New Jersey / / Technology Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
6706905M Rev. May 2012 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DESONATE®